SANUWAVE Health (SNWV) EBITDA (2010 - 2026)

SANUWAVE Health (SNWV) has reported EBITDA for 17 consecutive years, with -$143000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA fell 109.47% year-over-year to -$143000.0 in Q2 2026; TTM through Jun 2026 was $1.8 million, a 69.04% decrease from a year earlier, with the FY2025 full-year figure at $5.3 million, up 28.51% from the prior year.
• EBITDA was -$143000.0 for Q2 2026 at SANUWAVE Health, up from -$1.0 million in the prior quarter.
• Over five years, EBITDA peaked at $2.0 million in Q4 2024 and troughed at -$3.0 million in Q2 2022.
• A 5-year average of -$94777.8 and a median of $263500.0 in 2025 frame the typical range for EBITDA.
• Across the five-year window, EBITDA soared 379.28% in 2024 and slumped 250.15% in 2026, its largest moves.
• Over 5 years, EBITDA stood at -$1.5 million in 2022, then surged by 171.02% to $1.0 million in 2023, then jumped by 93.65% to $2.0 million in 2024, then slipped by 0.45% to $2.0 million in 2025, then tumbled by 107.14% to -$143000.0 in 2026.
• The last three EBITDA figures came in at -$143000.0 (Q2 2026), -$1.0 million (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.